[ Price : $8.95]
Roche says results from two Phase 3 studies evaluating Alzheimers therapy gantenerumab were not statistically significant in slowi...[ Price : $8.95]
Federal Register notice: FDA makes available a final guidance entitled Referencing the Definition of a Device in the Federal Food,...[ Price : $8.95]
Federal Register notice: FDA determines for patent term extension purposes the regulatory review period for Mercks Prevymis (leter...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled Q5A(R2) Viral Safety Evaluation of Biotechnology Products D...[ Price : $8.95]
Satsuma Pharmaceuticals says topline results from the STS101 SUMMIT Phase 3 efficacy trial showed numerical differences in favor o...[ Price : $8.95]
FDA grants ImmunoGen an accelerated approval for Elahere (mirvetuximab soravtansine-gynx) for treating certain adult patients with...[ Price : $8.95]
Insulet issues a Medical Device Correction for the Omnipod 5 Automated Insulin Delivery System because of an overheating issue wit...[ Price : $8.95]
Federal Register notice: FDA determines for patent extension purposes the regulatory review period for Mercks Prevymis (letermovir...